Enzene Sees Tariff Exemptions For India, Front-Ends US Capacity

 
• By Vibha Ravi
  
Himanshu Gadgil, CEO, Enzene Biosciences
Himanshu Gadgil, CEO, Enzene Biosciences (Enzene Biosciences Ltd)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from India

More from Strategy